HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Takeuchi Selected Research

Diabetes Complications

11/2005Decrease in the glyceraldehyde derived advanced glycation end products in the sera of patients with Vogt-Koyanagi-Harada disease.
5/2001Increased levels of vascular endothelial growth factor and advanced glycation end products in aqueous humor of patients with diabetic retinopathy.
1/2001Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Takeuchi Research Topics

Disease

12Atherosclerosis
05/2012 - 01/2003
11Insulin Resistance
01/2018 - 10/2000
11Diabetic Retinopathy (Retinopathy, Diabetic)
07/2011 - 05/2001
10Neoplasms (Cancer)
01/2023 - 03/2000
10Diabetic Nephropathies (Diabetic Nephropathy)
09/2014 - 01/2001
9Type 2 Diabetes Mellitus (MODY)
10/2015 - 05/2001
6Hyperglycemia
05/2015 - 01/2004
6Diabetes Mellitus
01/2006 - 12/2000
5Infections
01/2023 - 03/2000
5Body Weight (Weight, Body)
01/2018 - 06/2001
5Neoplasm Metastasis (Metastasis)
10/2014 - 07/2000
5Melanoma (Melanoma, Malignant)
05/2013 - 01/2004
5Leukemia
08/2011 - 03/2000
5Hepatocellular Carcinoma (Hepatoma)
09/2008 - 09/2000
5Inflammation (Inflammations)
09/2008 - 12/2001
5Alzheimer Disease (Alzheimer's Disease)
01/2007 - 01/2001
5Diabetic Angiopathies (Diabetic Angiopathy)
01/2007 - 01/2003
5Hypertension (High Blood Pressure)
01/2006 - 01/2005
4Disease Progression
01/2022 - 01/2000
4POEMS Syndrome (Syndrome, POEMS)
11/2015 - 05/2009
4Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
04/2013 - 08/2000
4Chronic Kidney Failure (Chronic Renal Failure)
02/2010 - 08/2000
4Wounds and Injuries (Trauma)
05/2006 - 05/2000
4Cardiovascular Diseases (Cardiovascular Disease)
01/2005 - 01/2000
4Infarction (Infarctions)
08/2001 - 06/2000
4Liver Cirrhosis (Hepatic Cirrhosis)
08/2001 - 09/2000
3Colorectal Neoplasms (Colorectal Cancer)
10/2023 - 01/2005
3Obesity
01/2018 - 01/2005
3Pancreatic Neoplasms (Pancreatic Cancer)
03/2016 - 01/2005
3Carcinoma (Carcinomatosis)
10/2014 - 09/2000
3Glucose Intolerance
01/2014 - 01/2005
3Breast Neoplasms (Breast Cancer)
05/2013 - 05/2000
3Proteinuria
02/2010 - 06/2003
3Venous Insufficiency
03/2009 - 04/2006
3Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2006 - 01/2005
3Diabetes Complications
11/2005 - 01/2001
3Myocardial Infarction
01/2005 - 10/2000
3Fibrosis (Cirrhosis)
11/2001 - 05/2000
2Muscular Dystrophies (Muscular Dystrophy)
01/2020 - 11/2001
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2017 - 06/2000
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2016 - 01/2000
2Lymphoma (Lymphomas)
01/2016 - 07/2001
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2015 - 08/2013
2Dyslipidemias (Dyslipidemia)
05/2015 - 01/2005
2Albuminuria
09/2014 - 07/2001
2Pain (Aches)
09/2012 - 03/2001
2Pneumonia (Pneumonitis)
12/2011 - 12/2000
2Multiple Myeloma
11/2011 - 11/2007
2Vascular System Injuries
09/2011 - 12/2006

Drug/Important Bio-Agent (IBA)

33Advanced Glycation End ProductsIBA
05/2015 - 01/2001
11Proteins (Proteins, Gene)FDA Link
02/2010 - 01/2000
8EnzymesIBA
06/2021 - 06/2000
7Glucose (Dextrose)FDA LinkGeneric
01/2018 - 10/2000
7Telmisartan (Micardis)FDA Link
03/2011 - 11/2005
6Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2004
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2015 - 05/2001
6Nifedipine (Adalat)FDA LinkGeneric
01/2007 - 01/2003
6Retinaldehyde (Retinal)IBA
01/2004 - 05/2001
5GlyceraldehydeIBA
09/2008 - 01/2002
4pigment epithelium-derived factorIBA
09/2008 - 02/2003
4PPAR gammaIBA
03/2008 - 01/2005
4AntibodiesIBA
06/2006 - 08/2000
4Insulin (Novolin)FDA Link
01/2006 - 10/2000
4ImmunosorbentsIBA
06/2005 - 05/2001
4CalciumIBA
01/2005 - 01/2004
41,4-dihydropyridine (dihydropyridine)IBA
01/2005 - 01/2004
4Adrenal Cortex Hormones (Corticosteroids)IBA
03/2001 - 02/2000
3Docetaxel (Taxotere)FDA Link
07/2015 - 09/2012
3Metformin (Glucophage)FDA LinkGeneric
05/2013 - 01/2005
3Receptor for Advanced Glycation End ProductsIBA
03/2011 - 01/2001
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2006 - 01/2006
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2006 - 01/2004
3SteroidsIBA
01/2005 - 06/2000
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2005 - 09/2003
3CytokinesIBA
01/2005 - 05/2000
3Hormones (Hormone)IBA
01/2002 - 01/2000
3Anti-Bacterial Agents (Antibiotics)IBA
05/2001 - 03/2000
3Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2001 - 04/2000
3Contrast MediaIBA
02/2001 - 06/2000
2VancomycinFDA LinkGeneric
01/2023 - 03/2000
2Bevacizumab (Avastin)FDA Link
01/2022 - 05/2009
2DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2017
2LipidsIBA
01/2018 - 01/2006
2Triglycerides (Triacylglycerol)IBA
01/2018 - 01/2005
2S-1 plus cisplatinIBA
09/2015 - 07/2015
2Cisplatin (Platino)FDA LinkGeneric
07/2015 - 08/2013
2Atorvastatin (Lipitor)FDA Link
05/2015 - 12/2006
2AdipokinesIBA
05/2015 - 01/2006
2Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric
12/2011 - 11/2000
2Sitagliptin Phosphate (Januvia)FDA Link
09/2011 - 08/2009
2CholesterolIBA
08/2011 - 01/2006
2Nateglinide (Starlix)FDA LinkGeneric
03/2011 - 03/2011

Therapy/Procedure

20Therapeutics
01/2017 - 01/2000
8Drug Therapy (Chemotherapy)
10/2023 - 01/2000
4Transplantation
04/2013 - 03/2006
3Stem Cell Transplantation
02/2016 - 01/2002
3Artificial Respiration (Mechanical Ventilation)
05/2010 - 11/2000
3Renal Dialysis (Hemodialysis)
11/2001 - 08/2000
2Catheters
05/2012 - 06/2006
2Endarterectomy (Thromboendarterectomy)
05/2010 - 07/2000